Paper28604239
Continuing challenges and current issues in acute lymphoblastic leukemia.
Kansagra A and 2 others. Leuk Lymphoma, 2018. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Continuing challenges and current issues in acute lymphoblastic leukemia. Papers, record 28604239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28604239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Molecular Targeted Therapy | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Humans |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40093906 | CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia. | Theranostics | 2025 | https://conductscience.org/library/papers/40093906 | PubMed |
| 40072099 | Advances in Therapy of Adult Patients with Acute Lymphoblastic Leukemia. | Cells | 2025 | https://conductscience.org/library/papers/40072099 | PubMed |
| 39607486 | Chidamide and venetoclax synergistically regulate the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL. | Ann Hematol | 2025 | https://conductscience.org/library/papers/39607486 | PubMed |
| 39542458 | The apoptotic and anti-proliferative effects of Neosetophomone B in T-cell acute lymphoblastic leukaemia via PI3K/AKT/mTOR pathway inhibition. | Cell Prolif | 2025 | https://conductscience.org/library/papers/39542458 | PubMed |
| 38195460 | Indigofera suffruticosa aerial parts extract induce G2/M arrest and ATR/CHK1 pathway in Jurkat cells. | BMC Complement Med Ther | 2024 | https://conductscience.org/library/papers/38195460 | PubMed |
| 36354684 | The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset. | Curr Issues Mol Biol | 2022 | https://conductscience.org/library/papers/36354684 | PubMed |
| 34615701 | Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach. | Eur Respir Rev | 2021 | https://conductscience.org/library/papers/34615701 | PubMed |
| 34026651 | The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies. | Front Oncol | 2021 | https://conductscience.org/library/papers/34026651 | PubMed |
| 33926261 | Inhibitory effect of hydnocarpin D on T-cell acute lymphoblastic leukemia via induction of autophagy-dependent ferroptosis. | Exp Biol Med (Maywood) | 2021 | https://conductscience.org/library/papers/33926261 | PubMed |
| 33566253 | Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL. | Invest New Drugs | 2021 | https://conductscience.org/library/papers/33566253 | PubMed |
| 33268820 | Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy. | Leukemia | 2021 | https://conductscience.org/library/papers/33268820 | PubMed |
| 33178020 | Transcriptome Profiling and Cytological Assessments for Identifying Regulatory Pathways Associated With Diorcinol N-Induced Autophagy in A3 Cells. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33178020 | PubMed |
| 33130821 | Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia. | Bone Marrow Transplant | 2021 | https://conductscience.org/library/papers/33130821 | PubMed |
| 32638188 | Functional and structural evaluation of the antileukaemic enzyme L-asparaginase II expressed at low temperature by different Escherichia coli strains. | Biotechnol Lett | 2020 | https://conductscience.org/library/papers/32638188 | PubMed |
| 31836919 | Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis. | Naunyn Schmiedebergs Arch Pharmacol | 2020 | https://conductscience.org/library/papers/31836919 | PubMed |
| 31771951 | The role of noncoding mutations in blood cancers. | Dis Model Mech | 2019 | https://conductscience.org/library/papers/31771951 | PubMed |
| 31662916 | Subdural Hygroma: A Morbid Complication of Intrathecal Chemotherapy in a Patient with B-Cell Acute Lymphocytic Leukemia. | Case Rep Hematol | 2019 | https://conductscience.org/library/papers/31662916 | PubMed |
| 30985716 | CD20-negative primary middle ear diffuse large B-cell lymphoma coexpressing MYC and BCL-2 secondary to acute lymphoblastic leukemia: A case report. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/30985716 | PubMed |
| 29651352 | Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse. | Case Rep Hematol | 2018 | https://conductscience.org/library/papers/29651352 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28604239
GET https://conductscience.org/api/papers/v1/28604239/authors